This document provides information about various aspects of a career as a biomedical scientist. It discusses the types of programs available for an MSc in biotechnology, including coursework and research requirements. It also addresses what daily life is like working in a research lab, including activities like lab meetings, organizing conferences, and supervising students. The document then discusses PhD programs and considerations for careers after completing a PhD, such as positions in science policy, scientific writing, or industry. Overall, the document provides an overview of the educational pathways and career options for someone pursuing a career as a biomedical scientist.
This document provides information about various aspects of a career as a biomedical scientist. It discusses the types of programs available for an MSc in biotechnology, including coursework and research requirements. It also addresses what daily life is like working in a research lab, including activities like lab meetings, organizing conferences, and supervising students. The document then discusses PhD programs and considerations for careers after completing a PhD, such as positions in science policy, scientific writing, or industry. Overall, the document provides an overview of the educational pathways and career options for someone pursuing a career as a biomedical scientist.
The document summarizes the company's 2Q16 earnings results. It notes that revenue and sales volumes declined across the company's segments compared to the previous year due to challenging market conditions in Brazil. Specifically:
- Revenue declined 13.8% to R$203.7 million due to falls in the chrysotile mineral, fiber-cement, and concrete tiles segments.
- Adjusted EBITDA declined 75.6% to R$10.6 million and the company reported a net loss of R$9 million.
- The company's consolidated net debt declined 12.6% compared to the previous quarter due to debt repayments, though debt-to-EBITDA ratios increased.
The document summarizes the key financial and operational highlights from Eternit's 1Q15 earnings call. It notes that while GDP and construction sector GDP in Brazil declined year-over-year, Eternit's net revenue grew 3.7% in 1Q15 driven by a 21.1% increase in foreign markets. Adjusted EBITDA was up 15.8% in 1Q15 compared to 1Q14. However, net income decreased 14.2% over the same period. The document also provides an overview of Eternit's business segments, debt levels, capital expenditures, shareholder base, and chrysotile mineral.
Eternit's earnings call summarized:
1) Eternit's 2Q12 revenue increased 5.0% to R$211 million compared to 2Q11 due to a 24.4% rise in EBITDA despite sales volume reductions in key products.
2) Margins improved with gross margin up 6 points to 44% and net margin up 3 points to 13% through increased efficiencies.
3) The company has a diversified portfolio including fiber cement, concrete tiles, bathroom products, and mining to drive future growth.
4) Capital investments of R$16 million in 2Q12 are expanding production capacity and developing new business lines like synthetic marble.
- The company's earnings results conference call covered declines in GDP, construction sector GDP, and sales volumes for the company's product segments in the second quarter of 2015 compared to the same period in 2014. However, consolidated net revenue increased 7.2% and adjusted EBITDA grew 15.5% for the quarter.
- Operational performance saw declines in the domestic market for all product segments, while the foreign market declined for chrysotile mineral and fiber cement but grew for concrete tiles.
- The company has a diversified debt repayment schedule and maintains reasonable debt levels relative to equity and EBITDA. Capital expenditures also continued during the period.
The document summarizes the company's 2Q16 earnings results. It notes that revenue and sales volumes declined across the company's segments compared to the previous year due to challenging market conditions in Brazil. Specifically:
- Revenue declined 13.8% to R$203.7 million due to falls in the chrysotile mineral, fiber-cement, and concrete tiles segments.
- Adjusted EBITDA declined 75.6% to R$10.6 million and the company reported a net loss of R$9 million.
- The company's consolidated net debt declined 12.6% compared to the previous quarter due to debt repayments, though debt-to-EBITDA ratios increased.
The document summarizes the key financial and operational highlights from Eternit's 1Q15 earnings call. It notes that while GDP and construction sector GDP in Brazil declined year-over-year, Eternit's net revenue grew 3.7% in 1Q15 driven by a 21.1% increase in foreign markets. Adjusted EBITDA was up 15.8% in 1Q15 compared to 1Q14. However, net income decreased 14.2% over the same period. The document also provides an overview of Eternit's business segments, debt levels, capital expenditures, shareholder base, and chrysotile mineral.
Eternit's earnings call summarized:
1) Eternit's 2Q12 revenue increased 5.0% to R$211 million compared to 2Q11 due to a 24.4% rise in EBITDA despite sales volume reductions in key products.
2) Margins improved with gross margin up 6 points to 44% and net margin up 3 points to 13% through increased efficiencies.
3) The company has a diversified portfolio including fiber cement, concrete tiles, bathroom products, and mining to drive future growth.
4) Capital investments of R$16 million in 2Q12 are expanding production capacity and developing new business lines like synthetic marble.
- The company's earnings results conference call covered declines in GDP, construction sector GDP, and sales volumes for the company's product segments in the second quarter of 2015 compared to the same period in 2014. However, consolidated net revenue increased 7.2% and adjusted EBITDA grew 15.5% for the quarter.
- Operational performance saw declines in the domestic market for all product segments, while the foreign market declined for chrysotile mineral and fiber cement but grew for concrete tiles.
- The company has a diversified debt repayment schedule and maintains reasonable debt levels relative to equity and EBITDA. Capital expenditures also continued during the period.
La Unión Europea ha acordado un embargo petrolero contra Rusia en respuesta a la invasión de Ucrania. El embargo prohibirá las importaciones marítimas de petróleo ruso a la UE y pondrá fin a las entregas a través de oleoductos dentro de seis meses. Esta medida forma parte de un sexto paquete de sanciones de la UE destinadas a aumentar la presión económica sobre Moscú y privar al Kremlin de fondos para financiar su guerra.